LEBER ET AL.
5 of 12
−
1
C H O, 2), 136 (13), 91 (24), 79 (40), 77 (45), 66 (100).
exo‐7‐butylbicyclo[3.2.0]hept‐2‐ene (5c). IR (cm )
11
16
1
H NMR (500 MHz, CDCl ) ∂ 5.82 (m, 1H), 5.70 (m
3047, 2922, 706. MS (EI) m/z 150 (M, C H , 1), 91 (5),
79 (10), 77 (5), 66 (100). H NMR (500 MHz, CDCl ). ∂
5.76 (m, 1H), 5.73 (m, 1H), 2.83 (br m, 2H), 2.55 (m,
1H), 2.15 (dp, 1H), 1.90 (m, 1H), 1.76 (m, 2H), 1.52 (m,
3
11 18
1
1
1
3
H), 3.72 (m, 1H), 3.53 (m, 1H), 3.39 (m, 1H), 2.58 (m,
3
H), 2.34 (m, 1H), 1.50 (m, 1H), 1.27 (m, 5H), 0.84 (t,
13
H). C NMR (125 MHz, CDCl , DEPT) ∂ 215.7
3
13
(C═O), 134.7 (═CH), 129.7 (═CH), 65.2 (CH), 59.3
2H), 1.31 (p, 2H), 1.23 (m, 2H), 0.90 (t, 3H). C NMR
(
CH), 42.3 (CH), 34.0 (CH ), 29.8 (CH ), 24.6 (CH ),
(125 MHz, CDCl , DEPT) exo‐5c: ∂ 133.9 (═CH), 130.1
2
2
2
3
2
2.6 (CH ), 13.9 (CH ).
(═CH), 51.6 (CH), 41.6 (CH), 40.6 (CH ), 36.3 (CH ),
2
3
2
2
endo‐7‐isopropylbicyclo[3.2.0]hept‐2‐en‐6‐one
IR (cm ) 3054, 2954, 1766, 776, 704. MS (EI) m/z
(4d).
32.73 (CH), 32.69 (CH ), 29.6 (CH ), 22.8 (CH ), 14.2
2 2 2
−
1
(CH ); endo‐5c: ∂ 132.0 (═CH), 131.2 (═CH), 49.7 (CH),
3
1
6
50 (M, C H O, 1), 122 (14), 107 (6), 91 (8), 79 (22),
40.2 (CH ), 38.5 (CH), 33.8 (CH ), 32.5 (CH), 31.5
10
14
2
2
9 (34), 66 (100), 51 (4); HRMS (EI) calcd for
(CH ), 29.7 (CH ), 22.8 (CH ), 14.2 (CH ).
2 2 2 3
1
−1
C H O (M 150.10447), found 150.10433. H NMR
exo‐7‐isopropylbicyclo[3.2.0]hept‐2‐ene (5d). IR (cm )
10
14
(
(
500 MHz, CDCl ) ∂ 5.85 (m, 1H), 5.81 (m, 1H), 3.71
m, 1H), 3.57 (m, 1H), 3.10 (m, 1H), 2.63 (m, 1H),
3048, 2952, 720. HRMS (EI) calcd for C H (M
3
10 16
1
136.1252), found 136.1258. H NMR (500 MHz, CDCl )
3
2
.38 (qq, 1H), 1.80 (m, 1H), 1.05 (d, 3H), 0.89 (d, 3H).
exo‐5d: ∂ 5.73 (m, 2H), 2.93 (br s, 1H), 2.70 (m, 1H),
2.54 (dd, 1H), 2.14 (d, 1H), 1.65 (m, 2H), 1.45 (m, 2H),
0.86 (d, 3H), 0.80 (d, 3H); endo‐5d: ∂ 0.78 (d, 3H), 0.66
13
C NMR (125 MHz, CDCl , DEPT) ∂ 214.7 (C═O),
3
1
4
34.7 (═CH), 129.9(═CH), 72.4 (CH), 58.6 (CH),
2.0 (CH), 33.8 (CH ), 26.0 (CH), 21.13 (CH ), 21.05
13
(d, 3H). C NMR (125 MHz, CDCl , DEPT) exo‐5d: ∂
2
3
3
(CH3).
134.2 (═CH), 130.0 (═CH), 49.8 (CH), 49.7 (CH), 40.7
endo‐7‐t‐butylbicyclo[3.2.0]hept‐2‐en‐6‐one (4e). IR
cm ) 3040, 2951, 1764, 1461, 740. MS (EI) m/z 164
(CH ), 32.9 (CH), 32.1 (CH), 30.9 (CH ), 19.8 (CH ),
2
2
3
−
1
(
(
(
1
1
19.5 (CH ); endo‐5d: ∂ 131.9 (═CH), 131.1 (═CH), 49.1
3
M, 1), 136 (15), 122 (5), 108 (22), 91 (18), 83 (99), 77
(CH), 46.5 (CH), 40.1 (CH ), 32.6 (CH ), 31.3 (CH), 30.0
2
2
1
32), 66 (100). H NMR (500 MHz, CDCl ) ∂ 5.90 (m,
(CH), 20.4 (CH ), 19.2 (CH ).
exo‐7‐t‐butylbicyclo[3.2.0]hept‐2‐ene (5e). IR (cm )
3056, 2930, 727. MS (EI) m/z 150 (M, C H , 6), 109
3
3
3
−
1
H), 5.78 (m, 1H), 3.65 (m, 1H), 3.60 (m, 1H), 3.36 (dd,
13
H), 2.64 (br d, 1H), 2.36 (qq, 1H), 0.98 (s, 9H).
C
11
18
1
NMR (125 MHz, CDCl , DEPT) ∂ 213.2 (C═O), 133.3
(8), 91 (18), 79 (31), 77 (18), 66 (100). H NMR
3
(
═CH), 131.0 (═CH), 75.3 (CH), 58.2 (CH), 42.9 (CH),
(500 MHz, CDCl ) exo‐5e: ∂ 5.73 (m, 2H), 2.98 (br s,
3
3
3.1 (CH ), 32.4 (C), 28.5 (CH ).
1H), 2.60 (p, 1H), 2.55 (m, 1H), 2.17 (m, 1H), 1.98 (m,
2
3
−
1
exo‐7‐ethylbicyclo[3.2.0]hept‐2‐ene (5a). IR (cm )
047, 2958, 1689, 711. MS (EI) m/z 122 (M, C H , 1),
1H), 1.77 (m, 1H), 1.60 (m, 1H), 0.87 (s, 9H); endo‐5e: ∂
13
3
9
0.81 (s, 9H). C NMR (125 MHz, CDCl , DEPT) ∂
9
14
3
1
3 (5), 91 (14), 79 (20), 77 (18), 67 (10), 66 (100). H
134.6 (═CH), 129.9 (═CH), 53.2 (CH), 47.4 (CH), 40.7
NMR (500 MHz, CDCl ) exo‐5a: ∂ 5.77 (m, 1H), 5.73
(CH ), 32.5 (CH), 31.8 (C), 28.3 (CH ), 26.2 (CH ).
3
2
2
3
−
1
(
m, 1H), 2.84 (m, 1H), 2.55 (qq, 1H), 2.15 (m, 1H),
.81 (m, 1H), 1.76 (m, 2H), 1.54 (m, 3H), 0.86 (t, 3H);
endo‐5a: ∂ 5.81 (m, 1H), 5.74 (m, 1H), 3.27 (br m, 2H),
exo‐5‐ethylbicyclo[2.2.1]hept‐2‐ene (6a). IR (cm )
3061, 2921, 703. MS (EI) m/z 122 (M, C H , 12), 91
1
9
14
1
(22), 77 (31), 66 (100). H NMR (500 MHz, CDCl ) exo‐
3
2
1
3
1
.68 (pent, 1H), 2.47 (m, 1H), 2.40 (p, 1H), 2.24 (dq,
6a: ∂ 6.06 (m, 1H), 6.00 (m, 1H), 2.76 (br s, 1H), 2.51 (br
H), 2.06 (m, 1H), 1.30 (m, 1H), 1.22 (m, 1H), 0.76 (t,
s, 1H), 1.38 (m, 2H), 1.28 (m, 2H), 1.23 (m, 2H), 1.05
13
13
H). C NMR (125 MHz, CDCl , DEPT) exo‐5a: ∂
(m, 1H), 0.91 (t, 3H); endo‐6a: ∂ 0.85 (t, 3H). C NMR
3
33.9 (═CH), 130.1 (═CH), 51.3 (CH), 43.4 (CH), 40.6
(125 MHz, CDCl , DEPT) exo‐6a: ∂ 136.94 (═CH), 136.2
3
(
CH ), 32.8 (CH), 32.4 (CH ), 29.4 (CH ), 11.7 (CH );
(═CH), 46.0 (CH), 45.2 (CH ), 41.8 (CH), 40.9 (CH),
2
2
2
3
2
endo‐5a: ∂ 132.1 (═CH), 131.0 (═CH), 49.5 (CH), 40.3
32.9 (CH ), 29.3 (CH ), 13.3 (CH ). endo‐6a: ∂ 136.87
2
2
3
(
CH), 40.2 (CH ), 33.5 (CH ), 32.2 (CH), 24.7 (CH ),
(═CH), 132.4 (═CH), 49.6 (CH ), 45.1 (CH), 42.5 (CH),
2
2
2
2
1
1.7 (CH3).
40.8 (CH), 32.2 (CH ), 27.6 (CH ), 13.0 (CH ).
2
2
3
−
1
−1
exo‐7‐propylbicyclo[3.2.0]hept‐2‐ene (5b). IR (cm )
endo‐5‐propylbicyclo[2.2.1]hept‐2‐ene (6b). IR (cm )
3046, 2931, 708. MS (EI) m/z 136 (M, C H , 6), 91 (5),
3
049, 2955, 2924, 1664, 716. MS (EI) m/z 136 (M,
1
0
16
1
1
C H , 2), 91 (7), 79 (13), 77 (8), 66 (100). H NMR
79 (6), 77 (5), 67 (5), 66 (100). H NMR (500 MHz,
10
16
(
500 MHz, CDCl ). ∂ 5.77 (m, 1H), 5.73 (m, 1H), 2.84
CDCl ) endo‐6b: ∂ 6.07 (dd, 1H), 5.89 (dd, 1H), 2.73 (br
3
3
(
1
br m, 2H), 2.55 (m, 1H), 2.15 (dt, 1H), 1.76 (q, 2H),
.50 (m, 2H), 1.28 (m, 3H), 0.89 (t, 3H). C NMR
m, 2H), 1.95 (m, 1H), 1.81 (ddd, 1H), 1.30 (m, 3H), 1.24
13
(d, 1H), 1.05 (m, 2H), 0.85 (t, 3H), 0.46 (m, 1H); exo‐6b:
13
(125 MHz, CDCl , DEPT) ∂ 133.9 (═CH), 130.1 (═CH),
∂ 0.88 (t, 3H). C NMR (125 MHz, CDCl , DEPT)
3
3
5
1.5 (CH), 41.3 (CH), 40.6 (CH ), 38.9 (CH ), 32.74
endo‐6b: ∂ 136.8 (═CH), 132.5 (═CH), 49.6 (CH ), 45.4
2
2
2
(
CH), 32.66 (CH ), 20.4 (CH ), 14.2 (CH ).
(CH), 42.5 (CH), 38.5 (CH), 37.1 (CH ), 32.4 (CH ), 21.7
2
2
3
2
2